You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 12, Issue 3

September 2019 - 41 articles

Cover Story: Zika virus (ZIKV) is a mosquito-borne flavivirus that spread throughout the American continent in 2015, causing considerable worldwide social and health alarm mainly due to its association with ocular lesions and microcephaly in newborns. Nowadays, no licensed vaccines or antivirals are available against ZIKV, and thus, in this very short time, the scientific community has conducted enormous efforts using different approaches to develop vaccines (inactivated, attenuated, or recombinant) and antivirals (direct-acting and host-targeting), with promising results. It is expected that this huge collaborative effort will produce affordable and effective therapeutic and prophylactic tools to combat ZIKV and other related still-unknown or currently neglected flaviviruses. This article is a comprehensive overview of the advances made in the development of therapeutic measures against ZIKV and the questions that still have to be faced. View this

Articles (41)

  • Article
  • Open Access
35 Citations
5,819 Views
18 Pages

Antimicrobial Photodynamic Therapy in Combination with Nystatin in the Treatment of Experimental Oral Candidiasis Induced by Candida albicans Resistant to Fluconazole

  • Karem Janeth Rimachi Hidalgo,
  • Juliana Cabrini Carmello,
  • Cláudia Carolina Jordão,
  • Paula Aboud Barbugli,
  • Carlos Alberto de Sousa Costa,
  • Ewerton Garcia de Oliveira Mima and
  • Ana Claudia Pavarina

18 September 2019

Background: It has been demonstrated that azole-resistant strains of Candida albicans have a greater resistance to antimicrobial photodynamic therapy (aPDT) when compared to their more susceptible counterparts. For this reason, the present study eval...

  • Review
  • Open Access
30 Citations
7,443 Views
13 Pages

17 September 2019

Iron chelation therapy, either subcutaneous or orally administered, has been used successfully in various clinical conditions. The removal of excess iron from various tissues, e.g., the liver spleen, heart, and the pituitary, in beta thalassemia pati...

  • Article
  • Open Access
9 Citations
4,917 Views
12 Pages

17 September 2019

The inhibitory activity of 14 racemic phosphonic acid analogs of phenylglycine, substituted in aromatic rings, towards porcine aminopeptidase N (pAPN) and barley seed aminopeptidase was determined experimentally. The obtained patterns of the inhibito...

  • Review
  • Open Access
12 Citations
5,184 Views
23 Pages

Predictive Power of In Silico Approach to Evaluate Chemicals against M. tuberculosis: A Systematic Review

  • Giulia Oliveira Timo,
  • Rodrigo Souza Silva Valle dos Reis,
  • Adriana Françozo de Melo,
  • Thales Viana Labourdette Costa,
  • Pérola de Oliveira Magalhães and
  • Mauricio Homem-de-Mello

16 September 2019

Mycobacterium tuberculosis (Mtb) is an endemic bacterium worldwide that causes tuberculosis (TB) and involves long-term treatment that is not always effective. In this context, several studies are trying to develop and evaluate new substances active...

  • Review
  • Open Access
11 Citations
5,427 Views
35 Pages

16 September 2019

Much evidence indicates that hypothalamus-derived neuropeptides, oxytocin, orexins A and B, inhibit nociceptive transmission in the rat spinal dorsal horn. In order to unveil cellular mechanisms for this antinociception, the effects of the neuropepti...

  • Review
  • Open Access
14 Citations
6,649 Views
28 Pages

Metal-Based Complexes as Pharmaceuticals for Molecular Imaging of the Liver

  • Julia Greiser,
  • Wolfgang Weigand and
  • Martin Freesmeyer

16 September 2019

This article reviews the use of metal complexes as contrast agents (CA) and radiopharmaceuticals for the anatomical and functional imaging of the liver. The main focus was on two established imaging modalities: magnetic resonance imaging (MRI) and nu...

  • Editorial
  • Open Access
41 Citations
7,501 Views
6 Pages

Special Issue “Anticancer Drugs”

  • Mary J. Meegan and
  • Niamh M. O’Boyle

16 September 2019

The focus of this Special Issue of Pharmaceuticals is on the design, synthesis, and molecular mechanism of action of novel antitumor, drugs with a special emphasis on the relationship between the chemical structure and the biological activity of the...

  • Feature Paper
  • Article
  • Open Access
27 Citations
6,356 Views
18 Pages

The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression

  • Brittany O’Brien,
  • Marijn Lijffijt,
  • Allison Wells,
  • Alan C. Swann and
  • Sanjay J. Mathew

11 September 2019

Childhood maltreatment is associated with a poor treatment response to conventional antidepressants and increased risk for treatment-resistant depression (TRD). The N-methyl-D-aspartate receptor (NDMAR) antagonist ketamine has been shown to rapidly i...

  • Article
  • Open Access
8 Citations
5,579 Views
12 Pages

Effect of 6-Shogaol on the Glucose Uptake and Survival of HT1080 Fibrosarcoma Cells

  • Angie C. Romero-Arias,
  • Luis G. Sequeda-Castañeda,
  • Andres F. Aristizábal-Pachón and
  • Ludis Morales

9 September 2019

Ginger is a plant that is native to southern China. In the last decade and research on the components of ginger has significantly increased; of these components, 6-shogaol exhibits the greatest potential antitumor capacity. However, the molecular mec...

  • Review
  • Open Access
48 Citations
8,866 Views
29 Pages

Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features

  • L. Tom Vlasveld,
  • Roel Janssen,
  • Edouard Bardou-Jacquet,
  • Hanka Venselaar,
  • Houda Hamdi-Roze,
  • Hal Drakesmith and
  • Dorine W. Swinkels

9 September 2019

Iron overloading disorders linked to mutations in ferroportin have diverse phenotypes in vivo, and the effects of mutations on ferroportin in vitro range from loss of function (LOF) to gain of function (GOF) with hepcidin resistance. We reviewed 359...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247